Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

XOMA Royalty (XOMA) Accumulated Expenses (2016 - 2025)

XOMA Royalty's Accumulated Expenses history spans 11 years, with the latest figure at $4.1 million for Q3 2025.

  • For Q3 2025, Accumulated Expenses rose 68.67% year-over-year to $4.1 million; the TTM value through Sep 2025 reached $4.1 million, up 68.67%, while the annual FY2024 figure was $5.8 million, 107.8% up from the prior year.
  • Accumulated Expenses for Q3 2025 was $4.1 million at XOMA Royalty, up from $281000.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $6.1 million in Q1 2023 and bottomed at $55000.0 in Q4 2021.
  • The 5-year median for Accumulated Expenses is $1.3 million (2024), against an average of $2.1 million.
  • The largest annual shift saw Accumulated Expenses skyrocketed 5205.45% in 2022 before it plummeted 94.23% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $55000.0 in 2021, then surged by 5205.45% to $2.9 million in 2022, then dropped by 5.14% to $2.8 million in 2023, then soared by 107.8% to $5.8 million in 2024, then decreased by 28.13% to $4.1 million in 2025.
  • Per Business Quant, the three most recent readings for XOMA's Accumulated Expenses are $4.1 million (Q3 2025), $281000.0 (Q2 2025), and $1.2 million (Q1 2025).